Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
about
Amitriptyline for neuropathic pain in adultsAntidepressants for the treatment of depression in people with cancerAmitriptyline for neuropathic pain and fibromyalgia in adultsRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewA phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management.Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Therapeutic strategies for cancer treatment related peripheral neuropathies.Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathyAntinociceptive effects of hydroalcoholic extract from Euterpe oleracea Mart. (Açaí) in a rodent model of acute and neuropathic pain.The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Cancer-related depression and potential pharmacologic therapiesTargeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trialRandomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsCurrent challenges and future prospects in management of neuropathic pain.The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathySodium channel blockers for the treatment of neuropathic pain.Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors.Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners.Chemotherapy-induced peripheral neuropathy: prevention and treatment.Coanalgesics for chronic pain therapy: a narrative review.Management of pain in the elderly at the end of life.Treatment for neuropathic pain in patients with cancer: comparative analysis of recommendations in national clinical practice guidelines from European countries.Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review.Management options for established chemotherapy-induced peripheral neuropathy.Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?Pharmacological Management of Cancer-Related Pain.Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review.Pain in chemotherapy-induced peripheral neurotoxicity.Oxaliplatin-induced neuropathy in colorectal cancer
P2860
Q24186538-0A09BA1E-5D3D-49F1-B269-1ABC5EDBA16AQ24187358-58EA031B-E411-4A83-844D-53A3E50CF755Q24202439-4FFCB873-27A2-419E-877C-B872EFB5DF7FQ24616897-30C596B0-862F-4E9D-A361-037361EDAECCQ28270819-8AD00B3D-C0B5-4766-B96C-F4CA1FEE69DBQ33693343-A0D1F500-CFB6-47DB-9509-97CA5B0C7A3BQ33744706-DD06C4D2-4A58-41C4-A6FE-A3F6241592CFQ33792986-014C816D-CA4C-4B6C-A775-B8D3783FB402Q34038073-91F622F7-A815-4BA5-B156-998149B3FEA7Q34433406-816C2F6E-7924-484C-AC4E-DE5C7EB9E332Q35138445-E84D972C-8DB1-4475-9E63-73CC19AC1F5EQ35248852-1EED4265-540D-449B-B524-D484788ADD1AQ35248891-0DB0AB8A-13B9-4686-92B9-77D098679B51Q35680791-7C326C3B-81A6-4B3E-8CCA-23C9F85998A6Q35898610-B7D24276-C4DD-4888-AA09-36CC8663BB96Q36226275-8E867FD9-0713-4EED-B31A-84A9C50CC541Q36935565-B1824269-DC77-4EFE-8CD5-D23E47E2D46FQ37018248-B979389D-0807-4752-9CF1-198483873105Q37046151-AF0F4494-3FDA-4C39-ABA8-0EEE54BF16AEQ37133290-6F423FA6-03DF-4D87-8D3E-D65AA4B1170AQ37170634-CE337554-A6AB-479D-9BAC-D3FB8E0ECB65Q37318165-F1FC4651-DA12-41F6-AAF5-8E10542B26E5Q37417070-E0464213-9F05-48A3-B31C-17F8B80E83A6Q37605350-9386A9FB-8694-4A78-9A09-AD50F83A1D98Q37744263-44320DDC-8DEA-4B4D-8275-393D6BBF4B05Q37764968-D80B302E-B2D6-4124-AADD-96C0D434D02EQ37911252-06876E1E-4771-43AB-AF7A-3A4E07697F72Q37959164-5B083460-E4F2-4F7C-AFF1-90B86DE7C39FQ37998511-787BF600-0C54-4051-8985-64266C61B86BQ38077587-9DA7E16A-E9B1-4B66-8257-0ED41847CC85Q38191773-AE12BC14-94AC-4803-9590-DBC1C43BDB36Q38208769-77916D56-6FE6-40D3-8990-087FA65CC406Q38216217-AE453286-CA52-4403-BA28-8E8E0E16F1EBQ38254351-DF0A2292-E18B-4B0F-8C1B-3C1B4EEAB5FEQ38522262-380B07B9-0F42-493D-9ACE-AF7A4D67E607Q38652570-18B0F3F2-D748-4E0C-B9AB-F265F0F2D5CDQ38672359-4C96D16B-1A7D-4527-B3D6-FE6E1DFC21DAQ38840224-5519B7EC-5087-4B97-B4B7-D6E968283BC8Q39363713-AF4D366D-D876-4AE6-8C6B-BF6D2C86864CQ39803653-111BF454-090F-473B-A390-E9450A477F33
P2860
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@ast
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@en
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@nl
type
label
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@ast
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@en
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@nl
prefLabel
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@ast
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@en
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@nl
P2093
P1476
Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.
@en
P2093
Anna-Liisa Kautio
Maija Haanpää
Tiina Saarto
P356
10.1016/J.JPAINSYMMAN.2007.02.043
P50
P577
2007-11-05T00:00:00Z